Join Vasuda Healthcare Analytics, and invest with Bhavneesh Sharma, MBBS, MD, MBA (Finance, NYU-Stern)
I invite you to try Vasuda Healthcare Analytics, premium US Biotech/Pharma event driven investment research service (available in Seeking Alpha's Marketplace).
I have 20-years of clinical and research experience in academic and private practice/community settings, including at Harvard and Cornell affiliated hospitals. I also have an MBA in Finance, Financial Markets specialization from New York University's Stern School of Business (ranked among top 3 finance MBA programs in the U.S.). I run a biotech/pharma focused investment management firm, Vasuda Capital Management.
I am ranked among the top 15 financial bloggers on Tipranks based on the performance of stock picks.
The most important part of the service is the breaking insights on biotech/pharma companies that I post in the chat room. So please check the chat room at least once daily. I attend at least 1-2 investment/medical/biotechnology conferences a month and meet KOLs/experts/management, etc. My observations are shared with the subscribers only.
The second most important part of the service is the posts that I make suggestions on how to play near-term biotech/pharma events using options.
The third most important part of the service is the directional signals and posts that I provide on XBI enabling swing traders to trade 3X ETFs LABU and LABD. There are also directional signals on the S&P 500 index (so that you can trade SPY options or 3x ETFs like UPRO/SPXU). There is a separate chat room for it.
Another very important part of the service is to the ability to ask me questions, my opinion on individual biotech/pharma companies in the chat room and also gain insights from the trades of other members so that we can all benefit from over collective wisdom.
These subscriber only features are not available on my contributions on the public Seeking Alpha site.
I hope to see you in our investor community.
Bhavneesh Sharma, MD, MBA
- Founder/Editor, Vasuda Healthcare Analytics
- Insights contributor, SumZero's Buy-side Institutional Platform
- Founder, Vasuda Capital Management
Cumulative performance: Jan 2017 to March 14, 2019
Vasuda Biotech focused strategies: 33.4%
Biotech ETF, IBB: 28%
S&P 500 ETF, SPY=25%
Outperforming IBB by 540 basis points.
Outperforming SPY by 840 basis points.
(Using standardized time-weighted NAV)
Another recent account trading LABU/LABD and 30-40 individual biotechs plus options shorting is up 367 basis points since February 15, 2019 in just 32 days (till March 17, excluding commissions). This is the strategy I am adopting now for potential new client accounts, LABU/LABD swing trading is selected based on probabilities, support/resistance levels etc that are used by HFT algos and involves mathematical calculations and selling options before biotech events..
Please email bs2537(at)nyu(dot)edu to learn more about the money management services.
Monthly plan: free 14-day trial, then $50/month
Annual Plan: free 14-day trial, then $400/year), less than a small coffee/day: 30% savings.